What is PBH's health score?

Prestige Consumer Healthcare Inc. (PBH) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PBH's estimated fair value?

Based on our 5-year discounted cash flow model, Prestige Consumer Healthcare Inc.'s estimated fair value is $43.29 per share, representing a -8.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is PBH undervalued or overvalued?

Our model currently rates PBH as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PBH... Refresh in a moment for the full analysis.

Prestige Consumer Healthcare Inc. (PBH)

Healthcare Fair Value medium mixed

$47.18

Updated: 2026-06-06

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

58 Mixed

Relative Value

40 Weak

Capital Allocation

70 Healthy

Risk

50 Mixed

Est. Fair Value $43.29

DCF Upside -8.2%

Sector Rank #6066 of 6857

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.